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Abstract

Numerous bioethical recommendations are now available in the complex process of
communication with cancer patients. In this review, we have focused on the complex
process of managing patients with different types of oncologic digestive diseases,
immediately after the diagnosis is made.
We have analyzed the literature data on the topic. MEDSCAPE and PubMed
databases have been studied. Issues such as telling the truth to patients with digestive
cancer, the physician's responsibility in the psychological management of patients and
their relatives, the nurses’ duties, the consented death, the practice of euthanasia and
physician-assisted suicide (PAS) as well as the clinical research have been the main
targets of our study.
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Highlights

 Communication with the cancer patient about the development of the disease and the
oncologic management is the key to a successful oncologic therapy.

ethics, management, digestive cancers

 Cultural statements, laws and ethical rules have been largely developed and standardized
lately to create models of behavior for physicians, nurses and patient's family members,

to maximize the comfort and the life quality of cancer patients.
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Introduction
Bioethical rules should guide physicians in the
communication process with cancer patients. In this
review, we have focused on the complex process of
communication with patients suffering from different
types of oncologic digestive diseases, immediately after
diagnosis. Communicating the information about
diagnosis, treatment and prognosis to patients with
gastrointestinal cancer is the main issue concerning the
ethical aspect of the studied pathology (1). For more than
25 years, different committees composed of experts in
psychology, researchers in the field of oncology, patient’s
advocates and physicians have been preoccupied and
made efforts in creating a guideline to follow when it
comes to cancer patients. Throughout time, the central
ethical aspects studied have been the following: telling the
truth to the patient, the physician's responsibility for the
psychological management of patients and their relatives,
the nurses’ duties, the consent to death (2), the practice of
euthanasia, the physician-assisted suicide (PAS) (3) and
the clinical research (4).
The present review relates to the available data in the
literature regarding the ethics in oncologic digestive
diseases. MEDSCAPE and PubMed databases have been
studied, and terms such as ethics and gastrointestinal
cancer have been the search engines. From the entire
database, thirteen studies have been selected. Issues such
as: telling the truth to the patient, the physician's
responsibility for the psychological management of
patients and their relatives, the nurses’ duties, the consent
to death, the practice of euthanasia, the physician-assisted
suicide (PAS) and the clinical research have been the
main topics studied.

Discussions
 Telling the truth to patients with digestive cancers
Attitudes and practices of truth-telling to patients
diagnosed with digestive cancer have changed
substantially in the past decades (5). In clinical practice,
dilemmas of whether, when and how to tell the truth to
patients are sometimes very difficult to solve. Cultural
and individual differences interfere and these aspects have
magnified the difficulties in the communication with
digestive cancer patients. The prognosis of the disease can
influence the anxiety of patients when coping with
digestive cancer (6). The main approved approach related
to these patients is unitary but it is influenced by digestive
cancer location and stage. Patients playing an active role
in the diagnosis of digestive cancer are nowadays the first
target of screening programs. Making people aware of the
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importance of detecting digestive cancer in the early
stages is the concern of our current society. Spreading the
information regarding the screening procedure for
colorectal, esophageal or stomach cancer can lead in the
following decades not only to a better communication
with the cancer patient but also to a decrease in the
incidence of oncologic digestive diseases. The willingness
of patients to participate in screening programs makes it
easier for the physician to communication the subsequent
diagnosis. Patients concerned about their health are more
focused on "what to do next" than on the gravity of the
moment. They can play an active role in the diagnosis and
treatment management. However, the majority of patients
are discovered beyond the screening programs. To better
cope with the diagnosis, people need to preserve hope.
The means of treatment, the evolutionary and the
prognostic data should be correctly presented to patients
to ensure that the accurate information is given and the
right choice is made by the patient. However, ethnical
origins, religious beliefs, cultural differences and legal
regulations should be also respected.
 The physician's responsibility in the psychological
management of patients and their relatives
Advances in the psychological research have changed
the way of thinking about health and illness. The
biopsychosocial model relates to health and disease as the
product of a multitude of factors including biological
characteristics (such as genetic predisposition), behavioral
factors (such as lifestyle, stress, health beliefs) and social
conditions (such as cultural influences, family
relationships
and
social
support)
(7).
This
conceptualization of health and illness has many scientific
and practical benefits. Following this concept, a lot of
patients can reduce their risk of developing major medical
problems, receive adequate treatment and reduce healthrelated costs when asking for the treatment to an
interdisciplinary team including behavioral healthcare
providers (8-10). However, in the field of oncology,
things are more complicated. Facing the diagnosis of
cancer causes severe distress. Like the patient, the family
also feels the emotional discomfort of the patient. Patients
feel distressed during the onset, the course and the
outcome of the disease. The psychological support for the
patient and family members could minimize the impact of
the illness and can also contribute to an improved life
quality for both patients and relatives involved in
caregiving.
Physicians are focused on improving collaboration
and the illness perception among the family members,
patients and other healthcare professionals. In all this
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period, it is essential to support the patient and the family
throughout the course of the disease and the cancer
treatment. The therapeutic alliance with the family that
should be informed about all aspects of the digestive
cancer patient is a powerful tool to improve. Besides the
life quality of the patient, the psychological distress of the
family members who are involved in the patient’s support
should be improved. The physicians’ goal is to help the
patient's family face the anxiety and fears for patients
with digestive cancers and also, the capacity to meet
everyday problems (11). The impossibility of self-feeding
in eso-gastric cancers, the presence of stomata for easier
feeding, the presence of stomata for intestinal evacuation
are challenging for patients. One should plan meetings to
inform patients and home-care providers to accept the
new disability and to monitor the functionality of the
devices used. Special communication skills are required
to meet the family’s expectations during the discussions
regarding the aspects of the patient's everyday life (12).
Before meeting the family, it is essential to know the
details regarding the patient's family, such as
composition, residence, the living standards, the lifestyle
and the social life and, whenever possible, the aspects
about culture, values and spiritual beliefs. These aspects
will make it easier to cooperate when it comes to the
material and psychological resources throughout the
disease and what expectations they have from doctors and
medicine altogether (13). Planning whom to invite to a
meeting and the preparation of the meeting along with the
proper environment for it are issues that should be solved
beforehand. The physician should then investigate with
empathy all the emotions and beliefs that run in the family
and try to support the positive feelings of pain sharing.
Moreover, the physician should allow time to express the
negative feelings of anxiety and to advise the patient and
the family to deal with them in everyday life and the
change in habits required by the illness. However, the
patient should remain the core of the conversation. The
physician should emphasize the suffering, the
communication difficulties, the commitment to active
participation to treatment and the influence of emotional
distress on relatives. Counseling experience proved that
physicians should always be aware of the patient's
constant shifts, from the expectation of endless support
from the family members to the effort of being
autonomous and independent in the management of the
disease, and act consequently (12).
 Nurses’ responsibilities
The management of cancer patients required
specialized healthcare providers. An innovative class of

nurses to attend patients with gastrointestinal cancer is
now available in some specialized centers. The nurse's
role in caring for digestive cancer patients includes
knowledge on the oncologic disease pathophysiology, risk
factors identification, detection methods, clinical features,
available treatments, conventional and integrative holistic
nursing interventions and community resources. For
digestive cancer patients, nurses should be skilled in
monitoring and restoring the damaged functionality of the
devices used. They should inform patients and family
members on everyday use of tools and their cleaning and
should also tell them about possible side effects (13, 14).
 The consent to death, the practice of euthanasia and
physician-assisted suicide (PAS)
Physician-assisted suicide (PAS) is the most exciting
issue of present times (3, 15). Religious condemnation
and sometimes moral disapproval of suicide by the
society were associated with its criminalization in most
societies before the beginning of modern times (16, 17).
However, opinions regarding suicide have changed during
the 19th and the 20th century, which coincide with the
development of modern psychiatry, as an autonomous
discipline. In this field, the practitioners could investigate,
diagnose and treat anxiety, depression and other ailments
leading to suicide. The achievements in the psychiatric
field referred to mental illness opposite to the hypothesis
that consenting to death in end-stage diseases is related to
a psychiatric disorder or is determined by social or
psychological forces. These issues once contributed to the
decriminalization of suicide (18). In 1967, the wave of
accepting the idea of end-of-life choice appeared, even if
dominated by skepticism among the society and the
medical authority (19).
Along with the specialist’s evaluation of the medical
reasons for the patient's end-of-life decision, an
exhaustive psychiatric evaluation is required when
confronted with a request for PAS. Another concern of
the authorities, besides the elimination of possible mental
illness, was the idea that PAS can become a practice,
especially in vulnerable populations. Targets such as
increasing the patient's autonomy and adhering to
professional liabilities, as well as promoting for additional
research that focuses more directly on the patient-centered
perspective, are still imposed. Nowadays, PAS is legal in
4 states of the US and also in the Nederland. Even though
legitimate, the issue is not without discomfort for
physicians. Even the phrase itself "physician-assisted
suicide" is controversial. For example, Oregon's "Death
with Dignity Act" clearly states the physicians’ role as the
primary gatekeepers of assisted suicide. The physicians’
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duties are the insurance of the fact that the disease is
terminal, with a prognosis of maximum six months and
only if the patient requesting PAS acts voluntarily, being
capable of making decisions and being well informed
about his medical condition. Even under such conditions,
physicians may feel uncomfortable to assist PAS.
Besides the communication with the patient's physician
regarding all aspects of treatment and behavior when
facing digestive cancer, the psychiatrist's role as an expert
includes the evaluation of his decision-making capacity
and the clarification of discussions among treatment
participants (the physician, the family and, last but not
least, the patient) to minimize the possibility of undue
influence on a patient's ultimate decision (20).
 Clinical research
The newest oncologic therapies have led to an
increase of the mean survival time for patients with
advanced digestive cancer, for example almost fourfold
longer than expected with the best supportive care in
CRC. This good evolution was accomplished due to the
combination of chemotherapy and targeted biologic
agents. However, the identification of KRAS mutations
proved that the newest agents are targeting epidermal
growth factor receptors, such as cetuximab and
panitumumab, and therefore are not beneficial to patients
with mutations. This process of understanding what is of
maximum interest for the targeted therapy in colorectal
cancer has taken years (21). The time spent from the
presentation and publication of small, retrospective phase
II studies to widespread acceptance of the KRAS
predictive value and changes in oncologic guidelines was
lengthy enough. The process of data disclosure regarding
KRAS status and the treatment of advanced CRC patients
was effective in permitting timely decisions regarding the
ongoing publicly funded clinical trials and, whether or not
such decisions were rational and ethical is still
controversial (22).

Conclusions
The ethical aspects of the oncologic digestive diseases
are fundamental in managing patients. The ability of
physicians involved in diagnosis and treatment, the
support of psychiatrists, the interaction and
communication with family members, the support of
nurses and the law regulations in terms of allowing
assisted death are the pillars of an excellent ethical
attitude. The differences in culture, religious beliefs and
socioeconomic status make it very hard to have a global
approach. However, ethical rules should guide the
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physician's decisions in attending digestive cancer
patients.
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